Healthcare -
Biotechnology - NASDAQ - US
$ 13.25
5.16 %
$ 192 M
Market Cap
0.11
P/E
INBX - CHANGE IN WORKING CAPITAL
Change in Working Capital INBX - Inhibrx Biosciences, Inc.
15.3 M
LAST VALUE
69.59%
2 YEAR CAGR
29.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR